Find your next paid study

Indiana UniversityNCT07336381

Actual pay is set by the research site.

Phase 2

Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma

This is a phase 2, open label, parallel multi-arm study of mirdametinib in combination with radiation in participants with recurrent sporadic glioblastoma (GBM…

Neurofibromatosis 1 (NF1)

University of Alabama at BirminghamNCT07521657

~$75 – $2,000

Actual pay is set by the research site.

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

This is a non-interventional, observational study to provide insights into the short-term progression of GA secondary to AMD in participants aged ≥55 years. T…

Geographic Atrophy Secondary to Age-related Macular Degeneration

Complement TherapeuticsNCT07144137

~$10 – $1,050

Actual pay is set by the research site.

PregnancyOverweight and Obesity

Effect of Exercise Modality During Pregnancy on Childhood Obesity Risk

The overall objective of this proposal is to conduct a longitudinal prospective study of overweight/obese (OW/OB) pregnant women and their offspring to determi…

East Carolina UniversityNCT04805502

Actual pay is set by the research site.

Optimizing High Flow Nasal Cannula Oxygenation in Pediatric Airway Procedures: a Randomized Study

The purpose of this study is to investigate which flow rate (higher versus lower) is most effective at increasing apneic time and preventing greater than 5% dr…

Airway Disorder

The University of Texas Health Science Center, HoustonNCT06947902

Actual pay is set by the research site.

Phase 4

Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction

This research study evaluates a prescription eye drop called Vevye® (cyclosporine 0.1%) for adults who have meibomian gland dysfunction (MGD), a common eye con…

Meibomian Gland Dysfunction (MGD)

University of Alabama at BirminghamNCT07224529

~$25 – $1,000

Actual pay is set by the research site.

Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF IV

Six million Americans live with atrial fibrillation (AF), a heart rhythm abnormality that is a major risk factor for stroke and only half of those AF patients …

Atrial Fibrillation

University of Massachusetts, WorcesterNCT05236556

Actual pay is set by the research site.

Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss

This research is being done to determine whether a test that measures a "Visual Evoked Potential" can be used in a new way for individuals that have hearing lo…

Sensorineural Hearing LossHearing Loss

Dartmouth-Hitchcock Medical CenterNCT05107466

Actual pay is set by the research site.

InsomniaTBI (Traumatic Brain Injury)

Behavioral Treatment of Insomnia in Active-Duty Service Members With Traumatic Brain Injury

The objective of the study is to conduct a randomized controlled trial of Cognitive Behavioral Therapy for Insomnia (CBT-I) in a sample of active-duty sailors …

Large B-cell LymphomaRelapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma+4 more

~$10 – $1,050

Actual pay is set by the research site.

Noctem, LLCNCT06867666

Phase 2

A Phase 2 Trial of Emapalumab for the Prevention of CAR-T Cell Associated Toxicities

This research study involves assessing the impact of emapalumab as preventative management of CAR-T related cytokine release syndrome in participants with Non-…

Marcela V. Maus, M.D.,Ph.D.NCT06550141

~$75 – $3,000

Actual pay is set by the research site.

Phase 1

A Phase 1, Open-Label, Multicenter Study of INCA036978 in Participants With Myeloproliferative Neoplasms

This study will be conducted to determine the safety, tolerability, dose-limiting toxicity (DLT)s, and maximum tolerated dose (MTD) and/or recommended dose for…

Myeloproliferative Neoplasms

Incyte CorporationNCT07441694

~$150 – $4,200

Actual pay is set by the research site.

A Prospective Long-Term Follow-Up Study to Evaluate the Use of the Minder Device to Aid in Treatment After Actionable Event Identification in Patients Diagnosed With Epilepsy.

The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not wel…

EpilepsyEpilepsy (Treatment Refractory)